Dr. John E. McKinnon, MD

Dr. McKinnon practices at MUSC Physicians in Mount Pleasant, South Carolina.

Dr. McKinnon's NPI, 1891944526, was assigned on September 18, 2008. Dr. McKinnon holds South Carolina license 88710.

Dr. McKinnon's primary practice is MUSC Physicians, at 1208 2 Island Ct, Mount Pleasant, SC 29466 in Charleston County. The practice phone is (803) 286-4666.

Dr. McKinnon's primary practice is MUSC Physicians in Mount Pleasant, South Carolina. Dr. McKinnon is also affiliated with Henry Ford Hospital. The medical group on file is MUSC Health. Dmand AI also links Dr. McKinnon to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McKinnon practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. McKinnon's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. McKinnon's licenses on file in 2 states: South Carolina and Michigan.

CMS data shows 266 Medicare services from Dr. McKinnon across 10 procedure codes in 2024, for 178 Medicare patients. Medicare paid $20,344 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 178 Medicare patients who saw Dr. McKinnon in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McKinnon's median patient age at 60, with 41% women.

In 2024, Dr. McKinnon wrote 280 Medicare Part D claims for 33 patients. 60% of them were for generic drugs. CMS names the drug for 165 of them, across 12 drugs with 11 or more claims each, at $222,635 in total drug cost. In 2022, CMS named 265 claims across 9 drugs.

Dr. McKinnon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McKinnon as offering telehealth.

Dmand AI links 23 papers to Dr. McKinnon, published from 2012 to 2024. 2021 was the busiest year, with 4. The most frequent topics are COVID-19, SARS-CoV-2 and COVID-19 Drug Treatment. Dr. McKinnon has published most often in Int J Infect Dis. Dr. McKinnon's most frequent co-authors are Marcus John Zervos, MD, George J. Alangaden, MD and Indira Brar, MD.

Dmand AI links Dr. McKinnon to 5 clinical trials, 2 of them phase 2/3 studies. 1 is still active or recruiting. Conditions studied include COVID-19, HIV Infections and Inflammation.

CMS Open Payments shows 74 general payments to Dr. McKinnon from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 91% of the total. EMD Serono, Inc. paid the most, $48,883.